Skye Bioscience, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Skye Bioscience, Inc. (SKYE) reported Cash and Cash Equivalents, Period Increase (Decrease) of $639.46 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-03-02
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was $184.91K.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-09-30 was -$66.88K.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-06-30 was -$271.41K.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2017-03-31 was $315.45K.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $639.46K.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$23.37K, a 101.47% decline from fiscal 2018.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $1.59M, a 883.26% increase from fiscal 2017.
- Skye Bioscience, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $162.06K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 25 month | Cash and Cash Equivalents, Period Increase (Decrease) 29 month |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | $639.46K 10-K · filed 2021-03-02 | ||||||
| 2019-12-31 | -$23.37K 10-K · filed 2021-03-02 | ||||||
| 2018-12-31 | $1.59M 10-K · filed 2020-03-23 | ||||||
| 2017-12-31 | $184.91K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $118.02K derived: sum of 2 quarters · filed 2019-03-14 | -$153.39K derived: sum of 3 quarters · filed 2019-03-14 | $162.06K 10-K · filed 2019-03-14 | $195.13K 10-K · filed 2018-03-19 | ||
| 2017-09-30 | -$66.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$338.29K derived: sum of 2 quarters · filed 2017-11-14 | -$22.84K 10-Q · filed 2017-11-14 | -$277.95K derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2017-06-30 | -$271.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $44.04K 10-Q · filed 2017-08-11 | -$211.07K derived: sum of 3 quarters · filed 2018-03-19 | -$722.80K derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2017-03-31 | $315.45K 10-Q · filed 2017-05-12 | $60.34K derived: sum of 2 quarters · filed 2018-03-19 | -$451.39K derived: sum of 3 quarters · filed 2018-03-19 | -$1.68M derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2016-12-31 | -$255.11K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$766.84K derived: sum of 2 quarters · filed 2018-03-19 | -$2.00M derived: sum of 3 quarters · filed 2018-03-19 | -$3.16M 10-K · filed 2018-03-19 | |||
| 2016-09-30 | -$511.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$1.74M derived: sum of 2 quarters · filed 2017-11-14 | -$2.90M 10-Q · filed 2017-11-14 | -$4.02M derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$2.39M 10-Q · filed 2017-08-11 | -$3.51M derived: sum of 3 quarters · filed 2017-08-11 | $230.39K derived: sum of 4 quarters · filed 2017-08-11 | |||
| 2016-03-31 | -$1.16M 10-Q · filed 2017-05-12 | -$2.28M derived: sum of 2 quarters · filed 2017-05-12 | $1.46M derived: sum of 3 quarters · filed 2017-05-12 | $1.88M derived: sum of 4 quarters · filed 2017-05-12 | |||
| 2015-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $2.62M derived: sum of 2 quarters · filed 2017-03-10 | $3.04M derived: sum of 3 quarters · filed 2017-03-10 | $3.01M 10-K · filed 2017-03-10 | |||
| 2015-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $4.17M derived: sum of 2 quarters · filed 2016-11-09 | $4.14M 10-Q · filed 2016-11-09 | $3.32M derived: sum of 4 quarters · filed 2016-11-09 | |||
| 2015-06-30 | $424.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $393.94K 10-Q · filed 2016-08-12 | -$423.76K derived: sum of 3 quarters · filed 2016-08-12 | $72.77K derived: sum of 4 quarters · filed 2016-08-12 | |||
| 2015-03-31 | -$30.63K 10-Q · filed 2016-05-13 | -$848.32K derived: sum of 2 quarters · filed 2016-05-13 | -$351.79K derived: sum of 3 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$817.69K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | -$321.16K derived: sum of 2 quarters · filed 2016-03-21 | $207.33K 10-K · filed 2016-03-21 | ||||
| 2014-09-30 | $496.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.03M 10-Q · filed 2015-11-12 | |||||
| 2014-07-31 | -$10.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | -$7.24K derived: sum of 2 quarters · filed 2014-09-15 | -$12.95K 10-Q · filed 2014-09-15 | $2.08K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-06-30 | $528.49K 10-Q · filed 2015-08-14 | ||||||
| 2014-04-30 | $3.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | -$2.23K 10-Q · filed 2014-06-05 | $12.80K derived: sum of 3 quarters · filed 2014-06-05 | $20.24K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2014-01-31 | -$5.71K 10-Q · filed 2014-03-17 | $9.32K derived: sum of 2 quarters · filed 2014-03-17 | $16.76K derived: sum of 3 quarters · filed 2014-09-15 | $23.21K derived: sum of 4 quarters · filed 2014-09-15 | |||
| 2013-10-31 | $15.04K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $22.47K derived: sum of 2 quarters · filed 2014-09-15 | $28.93K derived: sum of 3 quarters · filed 2014-09-15 | $25.78K 10-K · filed 2014-01-27 | |||
| 2013-07-31 | $7.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $13.89K derived: sum of 2 quarters · filed 2014-09-15 | $10.75K 10-Q · filed 2014-09-15 | $20.23K derived: sum of 4 quarters · filed 2014-09-15 | $37.15K 10-Q · filed 2013-09-16 | ||
| 2013-04-30 | $6.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $3.31K 10-Q · filed 2014-06-05 | $12.79K derived: sum of 3 quarters · filed 2014-06-05 | $13.50K derived: sum of 4 quarters · filed 2014-06-05 | $29.71K 10-Q · filed 2013-06-27 | ||
| 2013-01-31 | -$3.14K 10-Q · filed 2014-03-17 | $6.34K derived: sum of 2 quarters · filed 2014-03-17 | $7.05K derived: sum of 3 quarters · filed 2014-03-17 | ||||
| 2012-10-31 | $9.48K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $10.19K derived: sum of 2 quarters · filed 2014-01-27 | $12.49K 10-K · filed 2014-01-27 | ||||
| 2012-07-31 | $707.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-16 | $3.01K 10-Q · filed 2013-09-16 | |||||
| 2012-04-30 | $2.30K 10-Q · filed 2013-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |